Skip to main content
. 2018 Jul 31;9(59):31459–31472. doi: 10.18632/oncotarget.25838

Figure 4. The expression of AGR2 in metastatic lesions.

Figure 4

(A) photomicrographs showing the immunoexpression of AGR2 in HGEC primary endometrial cancer and matched metastatic lesion (×400 magnification). (B) Immunoscores of AGR2 in primary tumours vs matched metastases.